165 related articles for article (PubMed ID: 37805623)
21. Association between idiopathic pulmonary fibrosis and risk of different pathological types of lung cancer: a Mendelian randomization study.
Zheng H; Nie D; Huang X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7751-7757. PubMed ID: 37009919
[TBL] [Abstract][Full Text] [Related]
22. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy.
Rinne R; Saukko P; Järvinen M; Lehesjoki AE
Ann Med; 2002; 34(5):380-5. PubMed ID: 12452481
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity.
Keyszer G; Lambiri I; Keysser M; Keysser C; Nagel R; Burmester GR; Jung K
Z Rheumatol; 1998 Dec; 57(6):392-8. PubMed ID: 10025098
[TBL] [Abstract][Full Text] [Related]
24. Activities of serum cathepsin (B, H and L) and metalloproteinase (MMP7-ase) in patients with gastrointestinal and bronchial malignant tumours.
László A; Sohár I; Karácsonyi S; Petri A; Troján I
Acta Med Hung; 1990; 47(1-2):107-9. PubMed ID: 2280991
[TBL] [Abstract][Full Text] [Related]
25. Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines.
Heidtmann HH; Salge U; Havemann K; Kirschke H; Wiederanders B
Oncol Res; 1993; 5(10-11):441-51. PubMed ID: 8054705
[TBL] [Abstract][Full Text] [Related]
26. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
Fröhlich E; Möhrle M; Klessen C
Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
[TBL] [Abstract][Full Text] [Related]
27. Association between psoriasis and lung cancer: two-sample Mendelian randomization analyses.
Wang X; Wang X; Wang H; Yang M; Dong W; Shao D
BMC Pulm Med; 2023 Jan; 23(1):4. PubMed ID: 36604675
[TBL] [Abstract][Full Text] [Related]
28. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.
Schweiger A; Staib A; Werle B; Krasovec M; Lah TT; Ebert W; Turk V; Kos J
Br J Cancer; 2000 Feb; 82(4):782-8. PubMed ID: 10732746
[TBL] [Abstract][Full Text] [Related]
29. Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study.
Liu J; Zhou H; Zhang Y; Huang Y; Fang W; Yang Y; Hong S; Chen G; Zhao S; Chen X; Zhang Z; Shen J; Xian W; Zhan J; Zhao Y; Hou X; Ma Y; Zhou T; Zhao H; Zhang L
Cancer Med; 2019 Apr; 8(4):1817-1825. PubMed ID: 30741477
[TBL] [Abstract][Full Text] [Related]
30. Risk mapping of lung cancer: a comprehensive appraisal of published meta-analyses incorporating Mendelian randomization studies.
Li C; Li J; Xiong S; Zhou H; Cai X; Xie Z; Peng H; Wu X; Zhong R; Jiang Y; Su Z; Zhu F; Huo Z; Liu B; Chi W; Wang H; Wen Y; Ge F; Feng Y; Wang R; Chen J; Chen Z; Shi J; Cheng B; Chen Z; Liang H; Li F; Deng H; He J; Liang W
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6857-6873. PubMed ID: 36809502
[TBL] [Abstract][Full Text] [Related]
31. Investigating Causal Associations of Circulating Micronutrients Concentrations with the Risk of Lung Cancer: A Mendelian Randomization Study.
Yan H; Jin X; Yin L; Zhu C; Feng G
Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364831
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells.
Gerber A; Wille A; Welte T; Ansorge S; Bühling F
J Interferon Cytokine Res; 2001 Jan; 21(1):11-9. PubMed ID: 11177576
[TBL] [Abstract][Full Text] [Related]
33. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.
Raghav N; Jangra S; Kumar A; Bhattacharyya S
Int J Biol Macromol; 2017 Jan; 94(Pt A):719-727. PubMed ID: 27780761
[TBL] [Abstract][Full Text] [Related]
34. Expression, proliferation activity and clinical significance of cathepsin B and cathepsin L in operated lung cancer.
Kayser K; Richter N; Hufnagl P; Kayser G; Kos J; Werle B
Anticancer Res; 2003; 23(3C):2767-72. PubMed ID: 12926111
[TBL] [Abstract][Full Text] [Related]
35. Differential expression patterns of cathepsins B, H, K, L and S in the mouse ovary.
Oksjoki S; Söderström M; Vuorio E; Anttila L
Mol Hum Reprod; 2001 Jan; 7(1):27-34. PubMed ID: 11134357
[TBL] [Abstract][Full Text] [Related]
36. The relationship of airflow limitation with lung squamous cell carcinoma: evidence from mendelian randomization analysis.
Zhang Q; Cai G; Cui F; Li F; Liang H; Gao L; Guo W; Li M; Chen Y
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6999-7006. PubMed ID: 36853385
[TBL] [Abstract][Full Text] [Related]
37. Cathepsins B, H and L in human breast carcinoma.
Gabrijelcic D; Svetic B; Spaić D; Skrk J; Budihna M; Dolenc I; Popovic T; Cotic V; Turk V
Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):69-74. PubMed ID: 1316176
[TBL] [Abstract][Full Text] [Related]
38. Cathepsins D, B, and L in malignant human lung tissue.
Ledakis P; Tester WT; Rosenberg N; Romero-Fischmann D; Daskal I; Lah TT
Clin Cancer Res; 1996 Mar; 2(3):561-8. PubMed ID: 9816204
[TBL] [Abstract][Full Text] [Related]
39. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
Azaryan AV; Hook VY
Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
[TBL] [Abstract][Full Text] [Related]
40. 2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.
Garg S; Raghav N
Bioorg Chem; 2016 Aug; 67():64-74. PubMed ID: 27285276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
